Juan Beauquis

ORCID: 0000-0003-1404-5632
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Alzheimer's disease research and treatments
  • Neurogenesis and neuroplasticity mechanisms
  • Neuroscience and Neuropharmacology Research
  • Regulation of Appetite and Obesity
  • Nerve injury and regeneration
  • Menopause: Health Impacts and Treatments
  • Axon Guidance and Neuronal Signaling
  • Stress Responses and Cortisol
  • Estrogen and related hormone effects
  • Mitochondrial Function and Pathology
  • Autophagy in Disease and Therapy
  • Neurological Disease Mechanisms and Treatments
  • Biochemical effects in animals
  • Diet and metabolism studies
  • Nuclear Receptors and Signaling
  • Adipose Tissue and Metabolism
  • Galectins and Cancer Biology
  • Advanced Glycation End Products research
  • Macrophage Migration Inhibitory Factor
  • Medical research and treatments
  • Medicinal Plants and Bioactive Compounds
  • Hypothalamic control of reproductive hormones
  • Adipokines, Inflammation, and Metabolic Diseases
  • bioluminescence and chemiluminescence research

Fundación Ciencias Exactas y Naturales
2012-2024

University of Buenos Aires
2006-2024

Experimental Medicine and Biology Institute
2013-2024

Consejo Nacional de Investigaciones Científicas y Técnicas
2013-2024

National Academies of Sciences, Engineering, and Medicine
2006-2009

Background Several brain disturbances have been described in association to type 1 diabetes humans. In animal models, hippocampal pathological changes were reported together with cognitive deficits. The exposure a variety of environmental stimuli during certain period time is able prevent alterations and improve learning memory conditions like stress, aging neurodegenerative processes. Methodology/Principal Findings We explored the modulation streptozotocin-induced diabetic mice by...

10.1371/journal.pone.0013993 article EN cc-by PLoS ONE 2010-11-15

Abstract Cerebral dysfunctions, including a high incidence of depression, are common findings in human type 1 diabetes mellitus. An association between depression and defective hippocampal neurogenesis has been proposed and, rodents, antidepressant therapy restores neuronal proliferation the dentate gyrus. Hippocampal is also deficient diabetic mice, which led us to study whether selective serotonin reuptake inhibitor fluoxetine influences cell streptozotocin‐diabetic animals. Diabetic...

10.1111/j.1460-9568.2006.04691.x article EN European Journal of Neuroscience 2006-03-01

In the context of Alzheimer's disease (AD), hippocampal alterations have been well described in advanced stages pathology, when amyloid deposition, inflammation and glial activation occur, but less attention has directed to studying early brain behavioral changes. Using an animal model AD, transgenic PDAPP-J20 mouse at 5 months age, no plaques are present low cerebral levels peptides detectable, we found structural, morphological, cellular hippocampus. Young mice showed a reduced volume with...

10.1002/hipo.22219 article EN Hippocampus 2013-10-16

Mitochondria are dynamic organelles that undergo fusion and fission processes. These events regulated by mitochondria-shaping proteins. Changes in the expression and/or localization of these proteins lead to a mitochondrial dynamics impairment may promote apoptosis. Increasing evidence correlates disruption with occurrence neurodegenerative diseases. Therefore, we focused on this topic Manganese (Mn)-induced Parkinsonism, disorder associated Mn accumulation preferentially basal ganglia where...

10.1371/journal.pone.0091848 article EN cc-by PLoS ONE 2014-03-14

Alzheimer's disease (AD) is a progressive neurodegenerative without effective therapy. Brain amyloid deposits are classical histopathological hallmarks that generate an inflammatory reaction affecting neuronal and glial function. The identification of early cell responses brain areas involved could help to design new successful treatments. Hence, we studied alterations hippocampal glia their progression during the neuropathology in PDAPP-J20 transgenic mice, AD model, at 3, 9, 15 months (m)...

10.1002/hipo.22503 article EN Hippocampus 2015-08-01

Abstract Type 1 diabetes mellitus correlates with several brain disturbances, including hypersensitivity to stress, cognitive impairment, increased risk of stroke and dementia. Within the central nervous system, hippocampus is considered a special target for alterations associated diabetes. Neurogenesis plastic event restricted few adult areas: subgranular zone dentate gyrus subventricular (SVZ). First, we studied ability neurogenesis in SVZ chronic diabetic mice induced by streptozotocin...

10.1111/j.1365-2826.2004.01223.x article EN Journal of Neuroendocrinology 2004-07-09

Dietary restriction promotes cell regeneration and stress resistance in multiple models of human diseases. One the conditions that could potentially benefit from this strategy is Alzheimer's disease, a chronic, progressive prevalent neurodegenerative disease. Although there are no effective pharmacological treatments for pathology, lifestyle interventions play therapeutic roles. Our objectives were 1) to evaluate effects dietary on cognition, hippocampal amyloid deposition, adult...

10.1016/j.nbd.2019.104542 article EN cc-by-nc-nd Neurobiology of Disease 2019-07-24

The hippocampus, a limbic structure linked to higher brain functions, appears vulnerable in diabetic subjects that have risk of stroke, dementia, and cognitive decline. dentate gyrus (DG) the hippocampus is one limited neurogenic areas during adulthood; neurons born DG are involved some types learning memory processes. We found decrease ability for proliferation neuronal differentiation newborn cells, measured by bromodeoxyuridine incorporation DG, from streptozotocin‐induced mice. hilar...

10.1111/j.1749-6632.2008.03983.x article EN Annals of the New York Academy of Sciences 2009-02-01

Subtype 3 metabotropic glutamate receptor (mGlu3R) displays a broad range of neuroprotective effects. We previously demonstrated that mGlu3R activation in astrocytes protects hippocampal neurons from Aβ neurotoxicity through stimulation both neurotrophin release and uptake. Alternative-spliced variants were found human brains. The most prevalent variant, mGlu3Δ4, lacks exon 4 encoding the transmembrane domain can inhibit ligand binding to mGlu3R. To date, neither its role neurodegenerative...

10.1111/jnc.15610 article EN Journal of Neurochemistry 2022-04-11
Coming Soon ...